ArticleMedical science monitor : international medical journal of experimental and clinical research2018

Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway.

Xianping Dai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.